Medicare AdvantagePrior AuthMedium impact
V-GO Insulin Delivery Device (Revised)
Humana·Endocrinology, Family Medicine, Internal Medicine +1 more·Medicare Advantage
Effective date
Jan 1, 2025
We identified it
Jun 24, 2026
Summary
Humana Medicare Advantage now requires prior authorization for V-GO insulin delivery devices (V-GO 20, 30, and 40) effective January 1, 2025. Patients must meet 8 specific criteria including failed trials of Omnipod and CeQur Simplicity devices before V-GO approval.
Action Required
Immediately: For V-GO insulin device prescriptions, obtain prior authorization from Humana Medicare Advantage before dispensing. Verify patients have failed 3-month trials of both Omnipod 5 AND CeQur Simplicity devices, meet insulin dosage requirements (20-76 units TDD, max 40 units basal, max 36 units bolus), and will use compatible insulin only. Visit www.humana.com/PAL for prior authorization submission. Claims will be denied without proper prior authorization.